Testing effectiveness (Phase 2)Active Not RecruitingNCT05627856
What this trial is testing
GNC-038 Injection in Patients With Relapsed or Refractory NK/ T-cell Lymphoma, AITL, and Other NHL
Who this might be right for
NK/T Cell LymphomaVascular Immunomother T Cell LymphomaNon-Hodgkin Lymphoma
Sichuan Baili Pharmaceutical Co., Ltd. 4